Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Call Transcript

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET Corporate Participants Marc Hedrick – President and Chief Executive Officer Andrew Sims – Vice President and Chief Financial Officer Norman LaFrance – Chief Medical Officer Conference Call Participants Justin Walsh – Jones Trading Sean Lee – H.C. Wainwright Edward Woo…

Read More

PROS Holdings, Inc. (PRO) Q3 2023 Earnings Call Transcript

PROS Holdings, Inc. (NYSE:PRO) Q3 2023 Earnings Conference Call October 31, 2023 4:45 PM ET Company Participants Belinda Overdeput – Director, IR Andres Reiner – President & CEO Stefan Schulz – CFO Conference Call Participants Chad Bennett – Craig-Hallum Capital Group Rob Oliver – Baird Jason Celino – KeyBanc Capital Markets Scott Berg – Needham…

Read More

Ferrovial, S.A. (FRRVF) Q3 2023 Earnings Call Transcript

Ferrovial, S.A. (OTCPK:FRRVF) Q3 2023 Earnings Conference Call October 31, 2023 1:00 PM ET Company Participants Silvia Ruiz – Head-Investor Relations Ernesto López Mozo – Chief Financial Officer Jose Velao – Chief Financial Officer-Cintra Iñaki Garcia-Bilbao – Chief Financial Officer-Ferrovial Construction Laura López – Chief Financial Officer-Ferrovial Airports Conference Call Participants Silvia Ruiz Good afternoon…

Read More

CVR Partners, LP (UAN) Q3 2023 Earnings Call Transcript

CVR Partners, LP (NYSE:UAN) Q3 2023 Earnings Conference Call October 31, 2023 11:00 AM ET Company Participants Richard Roberts – Director, Financial Planning and Analysis and IR Mark Pytosh – CEO Dane Neumann – CFO Conference Call Participants Rob McGuire – Granite Research Operator Greetings, and welcome to the CVR Partners LP Third Quarter 2023…

Read More

Catalyst Pharmaceuticals: Agamree Approval Selloff A Long-Term Buying Opportunity (CPRX)

koto_feja/E+ via Getty Images Company website Investment Thesis Rating Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Buy with 2-5 year target of $40 (3x upside) based on the discounted cash flow (“DCF”) valuation method. Steroids are used in 70% of patients with Duchenne’s muscular dystrophy, DMD, a debilitating neuromuscular disease, which is a 2 billion/year market and is…

Read More

VO: Better Valuations, Bullish Seasonals

Nikada Nearly all stocks outside of the US megacap Magnificent Seven have produced negative alpha this year. Stretch out the performance scope to five years, and you’ll also see heavy underperformance among value stocks, foreign equities, and domestic SMID caps. But did you know: It’s not big glamour stocks, strength overseas, or US small-caps that…

Read More

Leveraging War Risks With DFEN (NYSEARCA:DFEN)

guvendemir/E+ via Getty Images While many football fans know that the best offense is a good defense, the notion originated with the father of the United States and its first President, George Washington. In 1799, he wrote, “Make them believe, that offensive operations, often times, is the surest, if not the only (in some cases)…

Read More

Schlumberger: A Strong Quarter With Optimistic Prospects (NYSE:SLB)

JHVEPhoto Introduction Houston-based Schlumberger Limited (NYSE:SLB) released its third quarter 2023 results on October 20, 2023. Note: As indicated regularly, I have followed SLB quarterly since December 2018. This article updates my article published on July 26, 2023. 1: 2Q23 Results Snapshot SLB again exceeded analyst expectations with third-quarter 2023 adjusted earnings of $0.78 per…

Read More

October Action Call: Buy Rating On Big Lots (NYSE:BIG)

miniseries Company Overview Big Lots (NYSE:BIG), through its subsidiaries, operates as a home discount retailer in the United States. The Company offers products under various merchandising categories, such as the furniture category that includes upholstery, mattresses, case goods, and ready-to-assemble departments; seasonal category, which comprises patio furniture, gazebos, Christmas trim, and other holiday departments; soft…

Read More

Bouygues SA (BOUYF) Q3 2023 Earnings Call Transcript

Bouygues SA (OTCPK:BOUYF) Q3 2023 Earnings Conference Call October 31, 2023 4:00 AM ET Company Participants Pascal Grangé – Deputy Chief Executive Officer & Chief Financial Officer Christian Lecoq – Chief Financial Officer, Bouygues Telecom Conference Call Participants Nicolas Cote-Colisson – HSBC Nick Lyall – Société Générale Mathieu Robilliard – Barclays Jakob Bluestone – BNP…

Read More

BASF SE (BASFY) Q3 2023 Earnings Call Transcript

BASF SE (OTCQX:BASFY) Q3 2023 Earnings Conference Call October 31, 2023 6:00 AM ET Company Participants Stefanie Wettberg – SVP, Investor Relations Martin Brudermüller – Chairman Dirk Elvermann – CFO Conference Call Participants Christian Faitz – Kepler Cheuvreux Gunther Zechmann – Bernstein Sam Perry – UBS Matthew Yates – Bank of America Chetan Udeshi –…

Read More

Autodesk Stock: AI Capabilities Not Fully Priced In (NASDAQ:ADSK)

Laurence Dutton Overview Autodesk (NASDAQ:ADSK) notably underperformed the broader market last year, witnessing a stock decline of roughly 9% year-over-year. In comparison, the NASDAQ index (QQQ) saw an approximate rise of 27%. The continuous high-interest rate environment dampens the construction market’s pace, which continues to be Autodesk’s most significant market segment. Interestingly, Autodesk didn’t capitalize…

Read More

SOXL: Heightened Interest, Leveraged Problems

SweetBunFactory Investment (Sell) Thesis The Direxion Daily Semiconductor Bull 3X Shares (NYSEARCA:SOXL) ETF offers a three-fold daily exposure to the ICE Semiconductor index, encapsulating 30 US-listed semiconductor companies, making it a tempting tool for those bullish on the short-term outlook of this sector​​. However, its inherent leverage, coupled with a semiconductor industry grappling with high…

Read More

Andreessen Horowitz to Raise $3.4B Fund for Crypto Startups

Andreessen Horowitz, to date, is arguably one of the most prolific investors in the blockchain space. Andreessen Horowitz (a16z) is reportedly planning to raise a $3.4 billion fund that will be designated for early-stage and seed-stage crypto businesses. The development was shared by Axios, which also cited other sources. According to Axios, a16z, the Silicon…

Read More

Monte Rosa Therapeutics: Roche Partnership Deal Could Bring Added Value (NASDAQ:GLUE)

JazzIRT/iStock via Getty Images Monte Rosa Therapeutics (NASDAQ:GLUE) has been making good progress in advancing its pipeline of molecular glue degraders [MGDs]. The goal is to have protein-to-protein interaction to eliminate diseases but without binding pockets. Such an approach allows it to go after target indications that are thought to be undruggable with other small…

Read More

Intel’s Q3: If You Build It They Will Come (NASDAQ:INTC)

Justin Sullivan Investment Thesis Intel (NASDAQ:INTC) represents an attractive opportunity given the company’s strong financials and dominance in the semiconductor industry. Intel is meeting customer demand efficiently with new product launches, regaining process leadership through R&D and scaling efforts, expanding production capacity globally with government funding, and delivering strong financial performance including revenue and earnings…

Read More

Is Сrypto Winter Really Over?

After Bitcoin price closed above $32k last week, the macro bullish outlook was confirmed amid heightened institutional demand. The transition of the crypto winter to the spring season and a parabolic bull run are expected to take place in the coming months. As the trial for Sam Bankman-Fried (SBF), the former FTX boss, approaches the…

Read More

Harmonic Inc. (HLIT) Q3 2023 Earnings Call Transcript

Harmonic Inc. (NASDAQ:HLIT) Q3 2023 Earnings Conference Call October 30, 2023 5:00 PM ET Company Participants David Hanover – IR Patrick Harshman – President and CEO Walter Jankovic – CFO Conference Call Participants Simon Leopold – Raymond James Ryan Koontz – Needham and Company Steven Frankel – Rosenblatt George Notter – Jefferies Tim Savageaux –…

Read More